在三种选择中对雄激素缺乏治疗的偏好:焦点组研究研究
Hannah L Rush1,2, Sophie Merrick1, John Marshall3
1MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
BJU international
|July 31, 2025
概括
男人想要选择晚期前列腺癌治疗的选择. 许多人更喜欢口服的LHRH抗剂或通过皮肤的雌激素补丁,而不是传统的LHRH激动剂注射用于雄激素剥夺疗法 (ADT).
科学领域:
- 在瘤学瘤学.
- 患者为中心的护理
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗雄激素剥夺疗法 (ADT) 是晚期前列腺癌的主要治疗方法.
- 传统的ADT涉及素化激素释放激素 (LHRH) 激素激剂注射.
- 较新的ADT选择包括透皮雌激醇 (tE2) 补丁和口服LHRH抗剂.
研究的目的:
- 为了确定男性是否认为ADT选择很重要.
- 为了确定男性更喜欢哪个ADT选项.
- 探索影响男性ADT选择的因素.
主要方法:
- 五个重点小组与英国的24名男性进行了调查.
- 参与者包括有或没有前期前列腺癌或ADT的男性.
- 数据使用批判现实主义主题分析进行分析.
主要成果:
- 男人重视在ADT上有选择和参与决策.
- 大多数人更喜欢口服的LHRH抗体 (14/24) 或tE2贴片 (8/24) 而不是LHRH激动剂注射 (2/24).
- 主要影响因素包括副作用,物流和来自可信来源的建议.
结论:
- 男人希望在ADT中有选择,并且往往更喜欢替代LHRH激动剂注射的替代方案.
- 这些患者偏好应该为ADT策略的指导方针和报销决定提供信息.
相关概念视频
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Disorders of the Male Reproductive System
580
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
580
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K


